rs147738731

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004722.4(AP4M1):​c.1342G>A​(p.Ala448Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00025 in 1,613,332 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A448A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 2 hom. )

Consequence

AP4M1
NM_004722.4 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3

Conservation

PhyloP100: 2.19

Publications

7 publications found
Variant links:
Genes affected
AP4M1 (HGNC:574): (adaptor related protein complex 4 subunit mu 1) This gene encodes a subunit of the heterotetrameric AP-4 complex. The encoded protein belongs to the adaptor complexes medium subunits family. This AP-4 complex is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs from the trans-golgi network to the endosomal-lysosomal system. [provided by RefSeq, Jul 2008]
TAF6 (HGNC:11540): (TATA-box binding protein associated factor 6) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the smaller subunits of TFIID that binds weakly to TBP but strongly to TAF1, the largest subunit of TFIID. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2010]
TAF6 Gene-Disease associations (from GenCC):
  • Alazami-Yuan syndrome
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.038645953).
BP6
Variant 7-100106862-G-A is Benign according to our data. Variant chr7-100106862-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210207.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00025 (366/1461092) while in subpopulation MID AF = 0.00884 (51/5766). AF 95% confidence interval is 0.00691. There are 2 homozygotes in GnomAdExome4. There are 194 alleles in the male GnomAdExome4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004722.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AP4M1
NM_004722.4
MANE Select
c.1342G>Ap.Ala448Thr
missense
Exon 15 of 15NP_004713.2
AP4M1
NM_001363671.2
c.1363G>Ap.Ala455Thr
missense
Exon 15 of 15NP_001350600.1
AP4M1
NM_001438824.1
c.1363G>Ap.Ala455Thr
missense
Exon 16 of 16NP_001425753.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AP4M1
ENST00000359593.9
TSL:1 MANE Select
c.1342G>Ap.Ala448Thr
missense
Exon 15 of 15ENSP00000352603.4
AP4M1
ENST00000421755.5
TSL:1
c.1342G>Ap.Ala448Thr
missense
Exon 15 of 16ENSP00000412185.1
AP4M1
ENST00000429084.5
TSL:5
c.1363G>Ap.Ala455Thr
missense
Exon 15 of 15ENSP00000403663.1

Frequencies

GnomAD3 genomes
AF:
0.000243
AC:
37
AN:
152240
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000264
AC:
66
AN:
250032
AF XY:
0.000281
show subpopulations
Gnomad AFR exome
AF:
0.0000617
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00209
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000256
Gnomad OTH exome
AF:
0.000981
GnomAD4 exome
AF:
0.000250
AC:
366
AN:
1461092
Hom.:
2
Cov.:
34
AF XY:
0.000267
AC XY:
194
AN XY:
726884
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.000157
AC:
7
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00249
AC:
65
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52662
Middle Eastern (MID)
AF:
0.00884
AC:
51
AN:
5766
European-Non Finnish (NFE)
AF:
0.000179
AC:
199
AN:
1111990
Other (OTH)
AF:
0.000397
AC:
24
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000243
AC:
37
AN:
152240
Hom.:
0
Cov.:
32
AF XY:
0.000242
AC XY:
18
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41472
American (AMR)
AF:
0.000262
AC:
4
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00316
AC:
1
AN:
316
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000398
Hom.:
0
Bravo
AF:
0.000291
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000206
AC:
25
EpiCase
AF:
0.000327
EpiControl
AF:
0.000474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Mar 13, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function

Mar 09, 2020
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Uncertain:1
Dec 29, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary spastic paraplegia Uncertain:1
Jan 01, 2019
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AP4M1-related disorder Benign:1
Feb 22, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Hereditary spastic paraplegia 50 Benign:1
Sep 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.058
T
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.32
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.85
D
M_CAP
Benign
0.0072
T
MetaRNN
Benign
0.039
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.63
N
PhyloP100
2.2
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-0.45
N
REVEL
Benign
0.098
Sift
Benign
0.039
D
Sift4G
Benign
0.49
T
Polyphen
0.0080
B
Vest4
0.068
MVP
0.37
MPC
0.10
ClinPred
0.036
T
GERP RS
3.8
Varity_R
0.19
gMVP
0.46
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147738731; hg19: chr7-99704485; COSMIC: COSV57996136; COSMIC: COSV57996136; API